176 related articles for article (PubMed ID: 16911499)
1. Amiodarone-sirolimus/tacrolimus interaction in a pediatric heart transplant patient.
Nalli N; Stewart-Teixeira L; Dipchand AI
Pediatr Transplant; 2006 Sep; 10(6):736-9. PubMed ID: 16911499
[TBL] [Abstract][Full Text] [Related]
2. Significant sirolimus and dronedarone interaction in a kidney transplant recipient.
Tichy EM; Medwid AJ; Mills EA; Formica RN; Kulkarni S
Ann Pharmacother; 2010; 44(7-8):1338-41. PubMed ID: 20484171
[TBL] [Abstract][Full Text] [Related]
3. Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
DuBay D; Smith RJ; Qiu KG; Levy GA; Lilly L; Therapondos G
Liver Transpl; 2008 May; 14(5):651-9. PubMed ID: 18433069
[TBL] [Abstract][Full Text] [Related]
4. Prior Amiodarone Exposure Reduces Tacrolimus Dosing Requirements in Heart Transplant Recipients.
Breslin NT; Salerno DM; Topkara VK; Latif F; Restaino S; Takeda K; Takayama H; Farr M; Colombo PC; Jennings DL
Prog Transplant; 2019 Jun; 29(2):129-134. PubMed ID: 30845890
[TBL] [Abstract][Full Text] [Related]
5. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
[TBL] [Abstract][Full Text] [Related]
6. Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation.
Paramesh AS; Grosskreutz C; Florman SS; Gondolesi GE; Sharma S; Kaufman SS; Fishbein TM
Transplantation; 2004 Jan; 77(1):129-31. PubMed ID: 14724447
[TBL] [Abstract][Full Text] [Related]
7. Effect of coadministered HIV-protease inhibitors on tacrolimus and sirolimus blood concentrations in a kidney transplant recipient.
Barau C; Blouin P; Creput C; Taburet AM; Durrbach A; Furlan V
Fundam Clin Pharmacol; 2009 Aug; 23(4):423-5. PubMed ID: 19709321
[TBL] [Abstract][Full Text] [Related]
8. Interaction between tacrolimus and nefazodone in a stable renal transplant recipient.
Olyaei AJ; deMattos AM; Norman DJ; Bennett WM
Pharmacotherapy; 1998; 18(6):1356-9. PubMed ID: 9855339
[TBL] [Abstract][Full Text] [Related]
9. Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.
Schena FP; Pascoe MD; Alberu J; del Carmen Rial M; Oberbauer R; Brennan DC; Campistol JM; Racusen L; Polinsky MS; Goldberg-Alberts R; Li H; Scarola J; Neylan JF;
Transplantation; 2009 Jan; 87(2):233-42. PubMed ID: 19155978
[TBL] [Abstract][Full Text] [Related]
10. Case report: drug interaction between tacrolimus and amiodarone with QT prolongation.
Burger CI; Clase CM; Gangji AS
Transplantation; 2010 May; 89(9):1166-7. PubMed ID: 20440199
[No Abstract] [Full Text] [Related]
11. [Use of Sirolimus in five pediatric patients undergoing solid organ transplantation].
Roque E J; Ríos M G; Vignolo A P; Pinochet V C; Schultz M; Humeres A R; Delucchi A; Rius A M; Hepp K J
Rev Med Chil; 2008 May; 136(5):631-6. PubMed ID: 18769812
[TBL] [Abstract][Full Text] [Related]
12. Conversion to sirolimus with calcineurin inhibitor elimination vs. dose minimization and renal outcome in heart and lung transplant recipients.
Demirjian S; Stephany B; Abu Romeh IS; Boumitri M; Yamani MH; Poggio ED
Clin Transplant; 2009; 23(3):351-60. PubMed ID: 19208105
[TBL] [Abstract][Full Text] [Related]
13. Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Jensen GS; Wiseman A; Trotter JF
Liver Transpl; 2008 May; 14(5):601-3. PubMed ID: 18433068
[No Abstract] [Full Text] [Related]
14. Hypotension, as consequence of the interaction between tacrolimus and mirtazapine, in a patient with renal transplant.
Fraile P; Garcia-Cosmes P; Garcia T; Corbacho L; Alvarez M; Tabernero JM
Nephrol Dial Transplant; 2009 Jun; 24(6):1999-2001. PubMed ID: 19332869
[TBL] [Abstract][Full Text] [Related]
15. [Oral ulcers in kidney allograft recipients treated with sirolimus].
Fricain JC; Cellerié K; Sibaud V; Catros S; Taïeb A; Merville P
Ann Dermatol Venereol; 2008 Nov; 135(11):737-41. PubMed ID: 19061651
[TBL] [Abstract][Full Text] [Related]
16. Different renal toxicity profiles in the association of cyclosporine and tacrolimus with sirolimus in rats.
Lloberas N; Torras J; Alperovich G; Cruzado JM; Giménez-Bonafé P; Herrero-Fresneda I; Franquesa Ml; Rama I; Grinyó JM
Nephrol Dial Transplant; 2008 Oct; 23(10):3111-9. PubMed ID: 18469305
[TBL] [Abstract][Full Text] [Related]
17. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.
Watson CJ; Gimson AE; Alexander GJ; Allison ME; Gibbs P; Smith JC; Palmer CR; Bradley JA
Liver Transpl; 2007 Dec; 13(12):1694-702. PubMed ID: 18044728
[TBL] [Abstract][Full Text] [Related]
19. Considerations in sirolimus use in the early and late post-transplant periods.
Patel SJ; Elliott EN; Knight RJ; Gaber LW; Gaber AO
Expert Opin Drug Saf; 2009 Jul; 8(4):421-34. PubMed ID: 19522662
[TBL] [Abstract][Full Text] [Related]
20. Robust, high-throughput LC-MS/MS method for therapeutic drug monitoring of cyclosporine, tacrolimus, everolimus, and sirolimus in whole blood.
Koster RA; Dijkers EC; Uges DR
Ther Drug Monit; 2009 Feb; 31(1):116-25. PubMed ID: 19065123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
